How the Infant Formula Recall Will Impact Abbott's Revenue

How the Infant Formula Recall Will Impact Abbott's Revenue

Source: 
Motley Fool
snippet: 
  • Recall of baby formula and ongoing plant closure is hurting Nutritionals sales.
  • Abbott continues to wait for FDA clearance to resume production.
  • Overall, Abbott still achieved growth as other business segments compensated for the losses.